Search

Search Constraints

You searched for: Author/Creator Daher, May

Search Results

4. 657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma. (10th December 2020)

5. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. (10th December 2020)

6. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. (9th November 2020)

7. 657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma. (9th November 2020)

8. Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. Issue 24 (20th August 2021)

9. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes. Issue 7 (9th June 2017)

10. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. Issue 2 (26th February 2021)